Detail
| LncRNA Name | n340790 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | thyroid cancer |
| ICD-0-3 | C73.9 |
| Methods | qPCR, Western blot etc. |
| Sample | thyroid cancer tissues, cell line (SW579) |
| Expression Pattern | up-regulated |
| Function Description | Here, we found that the lncRNA n340790 was highly expressed in human thyroid cancer tissues and was strongly correlated with the clinical characteristics of patients. There was a good prognostic value of n340790 for thyroid cancer. Furthermore, we discovered that n340790 could act as an endogenous sponge by directly binding to miR-1254 and downregulating miR-1254 expression. |
| Pubmed ID | 28559970 |
| Year | 2017 |
| Title | The lncRNA n340790 accelerates carcinogenesis of thyroid cancer by regulating miR-1254 |
| External Links |
| Links for n340790 | GenBank HGNC lncrnadb Noncode |
| Links for thyroid cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.